This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

 

Virtual Symposium: Delivering Complex and Innovative Design (CID) Studies

Date: 04 February 2021
Time: 09:00 to 13:00
Location: Online

The clinical research landscape is changing and clinical trials are evolving to find new, faster and more efficient ways to bring new treatments to patients.

The UK Life Sciences Industrial Strategy (August 2017) and the Life Sciences Sector Deal 2 (December 2018) set out the Government’s commitment to consolidate the UK as a world-leader in delivering clinical trials using novel or complex designs and/or innovative approaches to research delivery. These have come to be known as CIDs (Complex Innovative Design studies).

The COVID19 pandemic is accelerating uptake and acceptance of this new era of clinical trials. This virtual event will generate discussion on where we were, where we are now, how we got there and where we go next.


Thursday 4 February 2021, 9:30 am


Programme

9:30 - 9:40 Chair’s Welcome and Department of Health and Social Care Introduction 

  • Sine Littlewood, Interim Business Development and Marketing Director, NIHR Clinical Research Network
  • Emma Lowe, Research Policy Senior Manager, Department of Health and Social Care

9:40 - 10:10 Panel: Pharma Perspectives

  • Host: Gareth Powell, Business Development Manager, NIHR CRN)
  • Hilary Coles, Strategic Account Lead for Clinical Research, Janssen Global Clinical Operations UK
  • Richard Marsden, Chief Executive Officer, Synairgen Plc
  • Philip Ross, Therapy Area Portfolio Manager, Novartis

10:10 - 10:40 Panel: Charity Perspectives

  • Host: Sine Littlewood, Business Development and Marketing Director, NIHR CRN
  • Dr Emma Gray, Head of Clinical Trials, MS Society
  • Dr Aoife Regan, Head of Clinical Research & ECMC Programme Office , CRUK
  • Dr Aisling McMahon, Executive Director of Research, Kidney Research UK

10:40 - 11:10 Panel: Regulatory, Funder and Academic Perspectives

  • Host: John Castledine, Head of Learning Development and Design, NIHR CRN
  • Dr Martin Ashton-Key, Scientific Director and Consultant in Public Health Medicine, NETSCC
  • Professor Julia Brown, Director, UKCRC Registered CTU Network and Leeds Institute of Clinical Trials Research
  • Dr Kirsty Wydenbach, Senior Medical Assessor, MHRA
  • Will Navaie, Engagement Manager, HRA

11.10 - 11.20 Comfort break (10mins)


11: 20 - 11:40 CID study showcase Q&A

  • Host: John Castledine, Head of Learning Development and Design, NIHR CRN
  • Using the Rare Renal Disease Registry (RaDaR) for Research: Dr Daniel Gale, St Peter’s Associate Professor of Nephrology, UCL Department of Renal Medicine
  • Why the UK is the perfect place to deliver clinical trials in rare kidney diseases: Using IgA nephropathy as an exemplar - Prof Jonathan Barratt Honorary Consultant Nephrologist, Leicester General Hospital
  • The NURTuRE study: a novel approach to maximise the impact of cohort studies: Prof Maarten Taal, Professor of Medicine, Centre for Kidney Research and Innovation, University of Nottingham

11.40 - 12.00 Q&A session: Tools and Support for Complex Innovative Designs

  • Host:Professor Matt Sydes, Professor of Clinical Trials and Methodology, UCL
  • Biomarker-Guided Trial Designs (BiGTeD): An online tool to help develop personalised medicine Professor Andrea Jorgensen
  • EcoNomics of Adaptive Clinical Trials (ENACT): Value-based adaptive clinical trial designs for efficient delivery of NIHR Research Laura Flight: Research Associate in Health Economics and Statistics
  • Practical Adaptive and Novel Designs and Analysis (PANDA): Munya Dimairo, Research Fellow in Medical Statistics

12.00 Final word from the chair

12.15 Close

Register for the event. Please note you will be prompted to create a login.